FDA Inspection 703069 — Anika Therapeutics, Inc.

Anika Therapeutics, Inc. — FEI 3007093114

The FDA completed an inspection of Anika Therapeutics, Inc. on December 22, 2010 in Bedford, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 22, 2010
Fiscal Year
2011
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Bedford, MA (United States)

Citations

IDCFRDescription
1472221 CFR 820.40Procedures not adequately established or maintained
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
54621 CFR 820.75(a)Lack of or inadequate process validation